Healthcare -
Biotechnology - NASDAQ - US
$ 5.16
-2.27 %
$ 46 M
Market Cap
-19.85
P/E
ICCC - CAPITAL EXPENDITURES
Capital Expenditures ICCC - ImmuCell Corporation
-1.89 M
LAST VALUE
14.83%
2 YEAR CAGR
1.39%
5 YEAR CAGR
-12.22%
10 YEAR CAGR